Clementia enrols children in ongoing Phase II trial of palovarotene to treat FOP
An additional clinical trial site has been added by the company in the UK to ease travel burden for affected individuals living in the European Union (EU). FOP
An additional clinical trial site has been added by the company in the UK to ease travel burden for affected individuals living in the European Union (EU). FOP
The deal provides Shire with access to Sanquin’s manufacturing technology and allowing the Irish firm to source additional manufacturers to meet the growing demand for Cinryze. Shire CEO
The product, which is the generic version of Pfizer’s Zosyn injection, is a combination of penicillin-class antibacterial and beta-lactamase inhibitor. According to IMS Health, Piperacillin and Tazobactam for
Currently underway in multiple sites in Canada, the US and Asia, the trial is designed to evaluate TKM-PLK1’s safety and efficacy in treating patients with HCC. In the
The grant will allow the company to progress OCD155 through pre-clinical development towards clinical trials and to further unravel the mechanism-of-action, which will be done in a Dutch-Danish-German-Swiss
Around 54 male patients will be enrolled in the trial, which is designed to evaluate the pharmacokinetics (PK), efficacy, and safety of rVIIa-FP in these patients who have
If etelcalcetide gets approval, it will be the first calcimimetic agent that can be administered intravenously at the end of the dialysis session. Etelcalcetide is a new calcimimetic
Canada-based Portage Biotech holds 54% equity interest in Biohaven Pharmaceutical Holding Company. With the completion of FDA review, Biohaven now plans to immediately proceed with a Phase I
HLD-200 uses Ironshore’s drug delivery platform, DELEXIS, to enable nighttime dosing of these patients. The multicenter, double-blind, randomized, placebo-controlled, parallel group Phase III trial (AHEAD) is designed to
Promacta is a once-daily oral thrombopoietin (TPO) receptor agonist that works by inducing stimulation and differentiation of megakaryocytes from bone marrow stem cells to increase platelet production. The